KRAS inhibitor-33

KRAS inhibitor-33 (compound 115a) is a potent pyrido[2,3-d]pyrimidine-based KRAS inhibitor with an IC50 of ≤100 nM. This small molecule is a valuable research tool for investigating KRAS-driven cancers in both in vitro cellular assays and in vivo model studies.